Yuanzhong Chen

Fujian Provincial Key Laboratory On Hematology, Fujian Medical University Union Hospital
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Real-World Delivery, Dose Adaptation, and Molecular Monitoring of Gilteritinib, Venetoclax, and Azacitidine in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia.

Real-World Delivery, Dose Adaptation, and Molecular Monitoring of Gilteritinib, Venetoclax, and Azacitidine in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 22, 2026

BCL-XL drives fibrotic and leukemic progression in myeloproliferative neoplasms.

BCL-XL drives fibrotic and leukemic progression in myeloproliferative neoplasms.

Journal: Frontiers in immunology

Published: February 27, 2026

Integrated transcriptome-proteome analysis in patients with myelofibrosis-related anemia.

Integrated transcriptome-proteome analysis in patients with myelofibrosis-related anemia.

Journal: Annals of hematology

Published: January 06, 2026

Roxadustat induces erythroid differentiation of erythroleukemia cells through the hypoxia inducible factor-α/GATA binding protein 1 axis.

Roxadustat induces erythroid differentiation of erythroleukemia cells through the hypoxia inducible factor-α/GATA binding protein 1 axis.

Journal: Cellular signalling

Published: October 07, 2025

Single-cell analysis reveals cytotoxic and memory CD8+ T cells associated with prolonged survival in relapsed/refractory leukaemia patients after haplo+cord haematopoietic stem cell transplantation.

Single-cell analysis reveals cytotoxic and memory CD8+ T cells associated with prolonged survival in relapsed/refractory leukaemia patients after haplo+cord haematopoietic stem cell transplantation.

Journal: Clinical and translational medicine

Published: July 22, 2025

Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review.

Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review.

Journal: Frontiers in oncology

Published: May 06, 2025

The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia.

The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia.

Journal: Pharmaceutics

Published: February 13, 2025

The hypoxia signaling pathway in the development of acute myeloid leukemia.

The hypoxia signaling pathway in the development of acute myeloid leukemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 13, 2025

Title Not Found

Title Not Found

Journal: Clinical and translational medicine

Published: November 05, 2023

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling.

Journal: Cell reports. Medicine

Published: October 31, 2023

TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT/GSK-3β and ERK signalling pathways.

TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT/GSK-3β and ERK signalling pathways.

Journal: Communications biology

Published: October 29, 2023

Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor.

Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 06, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026